EcoDrugPlus

Leukotriene A4 Hydrolase

Ensembl ID : ENSDNOG00000001969
Gene Symbol: LTA4H
4 Cross references
207 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSDNOG00000038475
Gene Symbol: LTB4R
2 Cross references
141 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSDNOG00000013361
Gene Symbol: KDM1A
2 Cross references
214 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSDNOG00000007180
Gene Symbol: LOXL2
4 Cross references
288 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSDNOG00000036327
Gene Symbol: MIF
3 Cross references
219 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSDNOG00000037280
Gene Symbol: MST1R
2 Cross references
268 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSDNOG00000046998
Gene Symbol: MMP1
4 Cross references
348 Possible Orthologues:

Matrix Metallopeptidase 12

Ensembl ID : ENSDNOG00000016544
Gene Symbol: MMP12
4 Cross references
560 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSDNOG00000009362
Gene Symbol: MMP13
2 Cross references
202 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSDNOG00000008414
Gene Symbol: MMP14
4 Cross references
272 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSDNOG00000016816
Gene Symbol: MMP2
4 Cross references
210 Possible Orthologues:

Matrix Metallopeptidase 3

Ensembl ID : ENSDNOG00000001886
Gene Symbol: MMP3
2 Cross references
502 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).